Bicara Therapeutics (BCAX) Interest Coverage Ratio (2023 - 2026)

Bicara Therapeutics' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 0.55 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 99.87% year-over-year to 0.55 in Q1 2026; TTM through Mar 2026 was 1.6, a 99.56% increase from a year earlier, with the FY2025 full-year figure at 1.59, down 13.99% from the prior year.
• Interest Coverage Ratio climbed to 0.55 in Q1 2026 per BCAX's latest filing, from 411.22 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 0.55 in Q1 2026 and bottomed at 1710.88 in Q4 2023.
• The 4-year median for Interest Coverage Ratio is 336.56 (2024), against an average of 427.69.
• Across the five-year window, Interest Coverage Ratio slumped 97.19% in 2025 and soared 99.87% in 2026, its largest moves.
• Year by year, Interest Coverage Ratio stood at 1710.88 in 2023, then jumped by 84.43% to 266.37 in 2024, then plunged by 54.38% to 411.22 in 2025, then surged by 99.87% to 0.55 in 2026.
• Per Business Quant, the three latest BCAX Interest Coverage Ratio figures stand at 0.55 (Q1 2026), 411.22 (Q4 2025), and 406.76 (Q3 2025).